Zenobia Therapeutics is a biotechnology and pharmaceutical company that was founded in 2008. The company recently received a significant $225.00K grant investment on 28 June 2019 from the National Science Foundation.
As an emerging player in the biotech and pharmaceutical industries, Zenobia Therapeutics has been attracting attention and investment from key organizations like the National Science Foundation. The recent investment is a testament to the potential and promise seen in the company's work.
With this latest injection of funds, Zenobia Therapeutics is poised to further its research and development efforts in the biotech and pharmaceutical sectors. The company's focus on cutting-edge innovations and solutions bodes well for its future growth and impact in these critical industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $225.00K | 1 |
|
28 Jun 2019 |
No recent news or press coverage available for Zenobia Fragments.
We care about your data, and we'd love to use cookies make your experience better.
